DaVita Inc. (NYSE:DVA) Shares Sold by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. lowered its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 10.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,380 shares of the company's stock after selling 2,200 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in DaVita were worth $2,965,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Wellington Management Group LLP grew its stake in DaVita by 9.1% during the 4th quarter. Wellington Management Group LLP now owns 2,711 shares of the company's stock worth $405,000 after purchasing an additional 227 shares in the last quarter. Hussman Strategic Advisors Inc. boosted its stake in shares of DaVita by 200.0% in the 4th quarter. Hussman Strategic Advisors Inc. now owns 25,200 shares of the company's stock valued at $3,769,000 after buying an additional 16,800 shares during the period. Fifth Third Bancorp grew its position in shares of DaVita by 5.0% during the first quarter. Fifth Third Bancorp now owns 4,274 shares of the company's stock worth $654,000 after buying an additional 204 shares in the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of DaVita during the fourth quarter worth approximately $597,000. Finally, Convergence Investment Partners LLC raised its holdings in DaVita by 33.2% in the fourth quarter. Convergence Investment Partners LLC now owns 11,389 shares of the company's stock valued at $1,703,000 after acquiring an additional 2,836 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have commented on DVA. Barclays increased their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 18th. Truist Financial lowered their target price on shares of DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research note on Monday, May 19th. Cowen restated a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Finally, Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, DaVita currently has a consensus rating of "Hold" and an average target price of $164.50.

DaVita Stock Down 0.6%

NYSE:DVA traded down $0.86 during midday trading on Wednesday, hitting $135.65. 833,544 shares of the company were exchanged, compared to its average volume of 821,537. DaVita Inc. has a fifty-two week low of $131.76 and a fifty-two week high of $179.60. The company has a market capitalization of $10.24 billion, a PE ratio of 13.44, a price-to-earnings-growth ratio of 0.95 and a beta of 1.11. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18. The company has a fifty day simple moving average of $140.92 and a 200 day simple moving average of $150.68.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The company had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same quarter last year, the company posted $2.26 earnings per share. The business's quarterly revenue was up 5.0% compared to the same quarter last year. As a group, equities analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.